Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company whose news flow centers on deployments, partnerships, regulatory developments, and capital markets activity related to its SteraMist systems and Binary Ionization Technology (BIT) platform. The company’s announcements highlight how its ionized Hydrogen Peroxide (iHP) technology is integrated into high-stakes environments where contamination control and infection prevention are essential.
Recent news releases describe multi-stage SteraMist iHP implementations at cell and gene therapy manufacturing sites, integration of SteraMist Integrated Systems into critical pharmaceutical manufacturing infrastructure, and installation of a SteraMist Hybrid System in a research university facility for reusable medical product sterilization. TOMI also reports on its role in life sciences and medical device sectors through a custom integration pipeline involving SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms, supported by partnerships with enclosure manufacturers.
Investors and industry observers following TOMZ news will find updates on TOMI’s outreach to cruise lines for advanced maritime decontamination, participation in sector events such as the American Association for Laboratory Animal Science National Meeting, and expansion into animal research and academic markets. The company’s releases also cover financial milestones, including quarterly results, pipeline updates, universal shelf registration filings, equity line of credit arrangements, and Nasdaq listing compliance notices.
This news page aggregates these disclosures, offering a centralized view of TOMI’s commercial projects, strategic relationships, regulatory and financing steps, and sector-focused initiatives involving its SteraMist and BIT-based disinfection technology.
TOMI Environmental Solutions (NASDAQ: TOMZ) said it is expanding into the food safety sector using SteraMist ionized Hydrogen Peroxide (iHP) technology to cut sanitation validation costs by up to 95%. A CPG partner reduced external testing and materials from about $100,000 to $5,000 annually.
The company reports the partner cut environmental sampling to once per quarter after implementation and has deployed SteraMist to multiple partner facilities, highlighting portability for deep machinery disinfection and potential scalability across food manufacturing sites.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced expansion across Canada on March 16, 2026, driven by multiple SteraMist iHP technology placements in leading hospital systems and Canada’s largest health research organization.
The company reported integrations in a special pathogens unit, deployments at a Nova Scotia trauma center and a research university, and increased Canadian distributor inventory to support direct-to-customer sales and ongoing competitive bids for the fiscal year.
TOMI Environmental Solutions (NASDAQ: TOMZ) appointed Total Clean Air as its Preferred European Partner for SteraMist iHP, making TCA the primary provider for sales, service, and technical support across the UK and EU. The agreement adds in-region validation, consignment stock, a UK showroom, and a dedicated workshop to support GMP Annex 1 compliance and surge demand in life sciences.
Market context includes a UK infection control market projected to exceed $6 billion by 2031 and a UK sterility testing market forecast at a 14% CAGR through 2035.
TOMI Environmental Solutions (NASDAQ: TOMZ) received Health and Safety Executive authorizations GB-2016-1042 (Great Britain) and NI-2026-1350 (Northern Ireland) on Feb. 23, 2026, allowing its Binary Ionization Technology (BIT) and SteraMist iHP products for registered biocidal uses.
Approvals cover room fogging and handheld surface spray on dry, pre-cleaned, hard, non-porous surfaces across healthcare, industrial, hospitality, and institutional sectors; specific EN and AOAC efficacy contact times are listed for bactericidal, yeasticidal, and virucidal claims.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced on Jan 20, 2026 the sale of a Custom Engineered System (CES) in the United Kingdom to an international pharmaceutical manufacturer. The CES integrates SteraMist iHP into Total Clean Air's modular cleanroom platform, the first deployment of iHP within that architecture. The integration is described as regulator-ready for MHRA and EMA expectations and intended to provide a repeatable, scalable decontamination model across pharmaceutical cleanrooms.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced the purchase and installation of a SteraMist Hybrid System in a new sterilization facility at a private East Coast research university on January 6, 2026.
The system will be used for repeatable, high‑level decontamination of reusable medical equipment distributed to patient homes and is intended to maintain isolation and minimize manual intervention during sterilization phases. This unit is the second SteraMist Hybrid sale within a $13 million automated installation pipeline that includes Custom Engineered Systems and the SteraMist Integrated System platform.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced on December 22, 2025 that a leading Cell and Gene Therapy manufacturer has adopted SteraMist ionized Hydrogen Peroxide (iHP) technology for a commercial-scale pharmaceutical facility.
The multi-stage implementation includes multiple SteraMist systems for surface treatment and automated room fogging, a full SOP development package, and an Installation and Operational Qualification (IQ/OQ) delivered by TOMI’s Qualification Team. TOMI’s iHP Corporate Service will perform whole-facility fogging across manufacturing suites, QC labs, and support spaces to support cGMP contamination control.
TOMI Environmental Solutions (NASDAQ: TOMZ) secured a signed purchase order valued at approximately $500,000 from a global biopharmaceutical leader to integrate the SteraMist iHP technology into passthrough fill boxes used in sterile manufacturing.
The contract covers full integration of the SteraMist Integrated Systems (SIS) platform across two manufacturing areas and includes comprehensive installation and performance qualification (PQ) services to meet regulatory validation requirements. The projects were previously included in a stated $13 million automated-installation pipeline, and TOMI expects further orders through 2026 and beyond.
TOMI Environmental Solutions (NASDAQ:TOMZ) on Dec. 15, 2025 urged cruise lines to adopt hospital-grade decontamination technology such as SteraMist to improve passenger and crew safety. TOMI highlighted cruise ships as concentrated, high‑risk environments for pathogens like Norovirus and Legionella and referenced recent outbreaks to argue for proactive, comprehensive disinfection beyond traditional cleaning.
The release says SteraMist can treat high‑risk areas (dining, crew quarters, clinics, children’s play areas, outdoor furniture), enable faster outbreak containment, reduce downtime, and increase passenger confidence. TOMI invites cruise operators and the public to partner with the company and provides contact info for assistance.
TOMI Environmental Solutions (NASDAQ:TOMZ) will present at the Sidoti Year End Investor Conference on December 11, 2025 at 2:30 PM ET. CEO Dr. Halden Shane and CFO David Vanston will be available for one-on-one meetings during the virtual conference on December 10-11, 2025. The presentation will cover TOMI's Binary Ionization Technology (BIT) platform and SteraMist product line for disinfection and decontamination.
Investors can register to watch the virtual presentation and contact investor relations at tomi@imsinvestorrelations.com for meeting requests.